 Connection
Nicholas Cost to Clinical Trials as Topic
This is a "connection" page, showing publications Nicholas Cost has written about Clinical Trials as Topic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.322 |
|
|
|
-
Mullen EA, Renfro LA, Ehrlich PF, Khanna G, Treece AL, Gratias EJ, Cost NG, Grundy PE, Fernandez CV, Dome JS, Geller JI. Feasibility of Real-Time Central Risk Assignment for Children's Oncology Group Pediatric Renal Tumor Trials. Pediatr Blood Cancer. 2026 Nov; 73(11):e70639.
Score: 0.168
-
Benedetti DJ, Cost NG, Ehrlich PF, Evageliou N, Fialkowski E, Parsons LN, Vallance KL, Renfro LA, Hong AL, Aldrink JH, Pater L, Paulino AC, Sandberg JK, Smith EA, Treece AL, Dome JS, Geller JI, Mullen EA. Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trials. Nat Rev Urol. 2025 11; 22(11):775-788.
Score: 0.154
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|